Workflow
Health
icon
Search documents
'It's a nightmare': Top Dem slams GOP megabill's Medicaid, SNAP cuts
MSNBC· 2025-07-01 02:31
What does it mean for motans. Uh, this bill, it's a nightmare like every other state. One out of two people in my state is on Medicaid if they're in assisted living.So, think about that. So, this they are literally giving tax cuts to the wealthiest, $400,000 tax cut to multi-millionaires on the backs of people in assisted living, kids who are getting kicked off of food assistance. And it is, as just pointed out correctly, over $4 trillion in debt, which is going to mean increased mortgage rates.It's going t ...
DRC Medicine Ltd. Announces the Business Combination Agreement with Ribbon Acquisition Corp.
Globenewswire· 2025-07-01 02:14
Company Overview - DRC Medicine Ltd. is an innovative healthcare and biotechnology company based in Tokyo, Japan, focusing on advanced medical technologies to address global health challenges [3][10] - The company is known for its proprietary Hydro Silver Titanium® technology, which is being developed into therapeutic masks for seasonal allergic rhinitis and a pipeline of In Vitro Diagnostic (IVD) kits for infectious diseases and allergen detection [3][10] - DRC Medicine is also negotiating to acquire an innovative ATP-enhancing drug for Parkinson's disease, currently in clinical trials [3][10] Business Combination Agreement - DRC Medicine has entered into a business combination agreement with Ribbon Acquisition Corp., a special purpose acquisition company, which will lead to DRC becoming publicly traded [2][4] - The proposed transaction implies a pre-money equity value of approximately $350 million for DRC on a fully diluted basis and is expected to provide around $50 million in cash from Ribbon's IPO proceeds [6][8] - Current shareholders of DRC Medicine will retain 100% of their equity and will own approximately 82.91% of the combined company on a pro forma basis, assuming no redemptions by Ribbon's shareholders [6][8] Strategic Focus and Market Trends - The company aims to invest in more IVD kits paired with AI-powered applications to enhance universal diagnostics, addressing the rising demand for better respiratory protection and faster, more accurate IVD kits [4] - DRC's management believes that the growth of airborne allergens, respiratory diseases, and infectious diseases presents significant market opportunities [4] - The combined company is expected to leverage its experienced management team and technology specialists to innovate and expand its healthcare and biotechnology applications in the global market [4]
Trump's 'debt bomb!' $3 trillion deficit-busting bill dubbed 'insane' by Musk (Melber report)
MSNBC· 2025-06-30 23:48
Breaking news out of Washington where the United States Senate is debating what would be as a factual matter the largest change and cut to the modern safety net in our time. President Trump's legislative agenda itself hangs in the balance. There are things in here that people think are very bad.Big cuts to healthcare. There are things that Trump says are very good. But all of it drives through this budget process.We can see the Senate floor where they have been having what they call a voterama. The final vo ...
'A moral obscenity': Top Democrat sounds off on GOP hypocrisy over Trump's megabill
MSNBC· 2025-06-30 21:45
We owe it to the states to do the work to understand how these proposals affect them. How hard is that. I did it.How hard is it. I'm telling the president that you have been misinformed. You supporting the Senate mark will hurt people who are eligible and qualified for Medicaid.Hi again everyone. I'm Elisi Menendez in for Nicole Wallace and it is five o'clock here in Washington DC where the voterama taking place in the Senate is still underway on that massive domestic spending bill. A bill that would drasti ...
X @Forbes
Forbes· 2025-06-30 21:20
5 Surprising Ways Too Much Screen Time Impacts Your Brain https://t.co/NKlkUWA5cP https://t.co/NKlkUWA5cP ...
GOP Senator is 'the best ad Democrats have going into midterms,' rips Trump's budget bill 
MSNBC· 2025-06-30 20:37
quote utterly insane and destructive. Quote, "An unhappy episode." The reviews are in, and even Republicans and their allies are warning about the consequences of Trump's so-called big beautiful bill. At this hour, the Senate is in the middle of a marathon voting session, taking up amendments to the bill from members of both parties.The goal to pass the bill later today. And rarely, if ever, have members of a political party seemed so glum on the eve of passing major legislation. With Democrats unified in t ...
CVS vs. Amazon: Healthcare Battle Continues- Which Stock to Buy Now?
ZACKS· 2025-06-30 20:01
Core Insights - Amazon's entry into healthcare has significantly disrupted the traditional pharmacy landscape, raising concerns for established players like CVS Health [1][3] - CVS Health is rebounding strongly in 2025, becoming one of the top performers in the S&P 500, with a focus on integrated care and leveraging its extensive physical presence [2][10] Group 1: Company Strategies - Amazon is leveraging its logistics capabilities and technology to redefine healthcare delivery, including AI-powered prescription fulfillment and at-home diagnostics [1][5][7] - CVS Health is capitalizing on its vast network of over 9,000 retail pharmacies and integrated services to provide coordinated care and improve patient outcomes [4][6] Group 2: Performance Metrics - CVS Health reported $95 billion in revenue in Q1 2025 and has achieved a year-to-date stock performance of 56%, ranking eighth in the S&P 500 [2][10] - In contrast, Amazon's stock has only risen by 1.8% year-to-date, placing it at number 262 in the S&P 500 rankings [10][9] Group 3: Financial Projections - The Zacks Consensus Estimate for CVS's 2025 earnings per share suggests a 12.7% improvement from 2024, indicating strong growth potential [12] - Amazon's 2025 EPS is projected to improve by 12.5% over the previous fiscal year, reflecting ongoing growth in its healthcare initiatives [14] Group 4: Valuation Comparisons - CVS is trading at a forward price-to-earnings ratio of 10.48X, which is above its five-year median, yet remains attractively valued compared to Amazon's 33.3X [15] - Amazon's current valuation is below its five-year median, suggesting potential for future growth but also indicating higher execution risk in its healthcare ventures [15][16]
Senate Starts Marathon Session for Trump’s ‘Big, Beautiful Bill’ | WSJ News
WSJ News· 2025-06-30 18:08
It's been a long debate. I know people are weary, but at the end of the day, we want to get this done so this country is safer and stronger and more prosperous. [Music] The Medicaid proposal in this bill bears no resemblance to that kind of discipline and due diligence.It has no insights into how these provider tax cuts are going to be absorbed without harming people on Medicare. We're going to make sure that we fulfill the promise and then we can feel I can feel good about a bill that I'm willing to vote f ...
Wellness 24/7 | Sarita Jadav | TEDxPodar Intl School Sangli
TEDx Talks· 2025-06-30 16:40
Uh my name is Sarita Jadav. I work as a national program officer in the UNESCO South Asia regional office based in New Delhi. And the work that uh I am involved in is on uh promoting health and wellness of learners and uh promote you know promoting safety and security and preventing violence in schools.I'd like to start by asking all of you over here in this esteemed gathering to please close your eyes for 15 seconds. Close your eyes for 15 seconds and imagine a 15-year-old child who is waking up with an al ...
Equasens: acquisition of DIS and RESURGENCES BUSINESSES
Globenewswire· 2025-06-30 16:00
Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET) PRESS RELEASE EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE ESTABLISHMENTS. Strengthening the position of a leading provider of software solutions for hospitals and the medical-social sector Growth strategy in action This acquisition is fully in line with Equasens' strategy for: developing software solutions for public health establishments, a market with numerous renew ...